Alphina Therapeutics website screenshot

Alphina Therapeutics

Alphina Therapeutics is a New Haven, Connecticut precision-oncology biotechnology company founded by experts in DNA repair and metabolic lethality. It develops next-generation antibody-drug conjugates (ADCs) that deliver potent NAMPT inhibitor payloads directly to tumors, designed to kill both dividing and non-dividing cancer cells, and pairs them with a proprietary companion diagnostic that identifies the patients most likely to respond. The company is venture-backed by Canaan Partners. It was surfaced as a portfolio company and added to the API Evangelist network as a stub; it publishes no public developer program, API, SDK, or documentation, so no API artifacts apply at this time.

Alphina Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Oncology, Therapeutics, and Antibody-Drug Conjugates.

Alphina Therapeutics’ developer surface includes engineering blog and 3 more developer resources.

6.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyOncologyTherapeuticsAntibody-Drug ConjugatesPrecision MedicineLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 6.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alphina-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 4

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: alphina-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alphina-therapeutics.png
name: Alphina Therapeutics
description: Alphina Therapeutics is a New Haven, Connecticut precision-oncology biotechnology company founded by experts
  in DNA repair and metabolic lethality. It develops next-generation antibody-drug conjugates (ADCs) that deliver potent NAMPT
  inhibitor payloads directly to tumors, designed to kill both dividing and non-dividing cancer cells, and pairs them with
  a proprietary companion diagnostic that identifies the patients most likely to respond. The company is venture-backed by
  Canaan Partners. It was surfaced as a portfolio company and added to the API Evangelist network as a stub; it publishes
  no public developer program, API, SDK, or documentation, so no API artifacts apply at this time.
url: https://raw.githubusercontent.com/api-evangelist/alphina-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Oncology
- Therapeutics
- Antibody-Drug Conjugates
- Precision Medicine
- Life Sciences
apis: []
common:
- type: Website
  url: https://www.alphinatx.com/
- type: Blog
  name: News
  url: https://www.alphinatx.com/news/
- type: LinkedIn
  url: https://www.linkedin.com/company/alphina-therapeutics
- type: Twitter
  url: https://twitter.com/alphinatx
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence